TARS vs V · rev $183.0M vs P/E 33, rev $40.00B
Tarsus Pharmaceuticals Inc (TARS) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
TARS currently screens at market cap $2.66B. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the TARS and V stock pages for the full models.
Not investment advice.